Wereport an unusual case of cytomegalovirus (CMV)interstitial pneumonitis (IP) occurring in a 51-year-old Japanese womanwith systemic lupus erythematosus (SLE). She developed hypoxemia after intensive immunosuppressive therapy with prednisolone and cyclophosphamide. Fine crackles were audible in the lower lungs bilaterally. Chest X-ray and computed tomography confirmed the presence of IP. CMV-antigenemia was confirmed by immunological staining of leukocytes using the peroxidase-labeled monoclonal antibody, HRP-C7. Hypoxemia improved gradually on methylprednisolone pulse therapy and gancyclovir, and CMV-antigen positive leukocytes disappeared from the peripheral blood. Data suggest the importance ofCMVas a cause of IP in SLE, and the usefulness of the assay for CMV-antigenemiawith C7-HRPfor rapid diagnosis. (Internal Medicine 35: 517-520, 1996) 
Introduction
Interstitial pneumonitis (IP) is a serious complication in immunocompromised patients such as those with hematological malignancies, or those undergoing allogeneic bone marrow transplantation (BMT) ( 1 , 2) . Pneumocystis carinii (P. carinii), cytomegalovirus (CMV), and the recently reported human herpes virus-6 (HHV-6) are the main causes of IP in acquired immunodeficiency disease (3). Even in patients with collagen disease, especially those with progressive systemic sclerosis (PSS), IP is one of the fatal pulmonary complications (4). IP develops in approximately 4%of systemic lupus erythematosus (SLE) patients (5); and acute lupus pneumonitis is diagnosed when bronchoalveolar lavage or transbronchial lung biopsy do not reveal infection (6). Although the pathogenesis appears to be varied, virological studies have not been conducted in patients with SLE complicated by idiopathic IP. Wereport a patient with SLEwho developed IP associated with CMVantigenemia following intensive immunosuppressive therapy with prednisolone (PSL) and cyclophosphamide (CPM). Wediscuss the importance of CMVin the pathogenesis of IP and the usefulness of monoclonal antibody for detecting CMV-antigenemia in SLE.
Case Report
This 54-year-old Japanese womandeveloped a high fever (up to 38°C) and adry cough in March 1994. She was diagnosed as having pancytopenia (hemoglobin 9.0 g/dl, white blood cells 2.0 x 109/jlx1 and platelets 48 x 109/jlx1) at a regional hospital, and was referred to our hospital on May 6, 1994 with a diagnosis of aplastic anemia. At age 36, she had undergone an oophorectomy because of uterine myomaand an ovarian cyst. On admission she was alert with a pulse rate of 90/min, respiratory rate 16/min, body temperature 38.2°C, and blood pressure 128/ 80 mmHg. Her palpebral conjunctiva was anemic, but bulbar conjunctiva did not appear jaundiced. A painless ulcer was observed on the pharynx. No abnormalities of the neck, chest or abdomenwere seen on physical examination. Nopetechiae or edemawere noted. Neurological findings were within normal limits. Laboratory data on admission (Table 1 ) revealed pancytopenia, and the bone marrowwas hypoplastic (data not shown). Renal damage was demonstrated by proteinuria, hematuria and the presence of numerous hyaline and granular casts in the urinary sediment. Initially suspecting a diagnosis of aplastic anemia complicated by bacterial infection, mepitiostane (15 mg/day), PSL (10 mg/day) and antibiotics were started. The patient' s body temperature decreased dramatically on the second day, but gradually rose again within a week. Serum tests were positive for antinuclear antibody (ANA), anti-RNP antibody and platelet associated IgG. However, serum tests for antiJo-1 antibody, anti-DNA antibody, and results of microsome and thyroid tests were all negative. The laboratory data and physical findings suggested a diagnosis ofSLE, and the dose of PSL was increased to 50 mg/day on May 17. The patient became afebrile for 20 days, but again developed a high fever on June 7. Weadded CPM, 50 mg/day, for 10 days, thereafter reduced to 25 mg/day, given in combination with PSL. On June 15, fine crackles were heard in the bases of the lungs. Arterial blood gas measurements were as follows: pH 7.505, PO2 81.5 mmHg,PCO2 31.0mmHg,HCO3 24.3 mEq//,BE 1.8 mEq// and Sat. O2 95.9%. Although the patient did not complain of dyspnea, chest X-ray revealed a slight fibrotic shadow in the bilateral lung bases. Computed tomography (CT) of the chest taken on August 5 clearly showed interstitial lung disease in the lung bases bilaterally (Figs. 1, 2) . At the same time, the serum lactic dehydrogenase (LDH) gradually rose to 1 ,092 IU// (Fig.  3) . To determine the cause of the IP in this patient, we performed a peripheral blood CMVantigen immunological assay using the horseradish peroxidase-labeled monoclonal antibody, HRP-C7, as described previously (7). Results revealed 13 CMVantigen positive leukocytes per 50,000 cells in the peripheral Systemic Lupus Erythematosus, Interstitial Pneumonitis, Cytomegalovirus blood, thus confirming the diagnosis of CMV-induced IP. We immediately initiated the administration of methylprednisolone (mPSL) pulse therapy (500 mg/day x three days) to treat the IP and gancyclovir (500 mg/day) for the CMVinfection, which resulted in the gradual reduction of the serum LDHlevel and a diminution of fine crackles in the lungs. The CMV-antigen positive cells disappeared after several weeks (Fig. 3) . The patient exhibited an elevation of the serum level of complements and a decreased titer ofANA,together with improvement in the SLE symptoms (data not shown).
Discussion
Patients with collagen disease show a high incidence of IP, especially those with PSS (4). In contrast, the incidence ofIP in SLE is only 4%(5). The clinical course of chronic interstitial lung disease in SLE is variable depending on the individual patient, but in most patients it follows a slow course and tends to improve or stabilize with time. But the prognosis is worse for patients with SLE complicated by rapidly progressing IP (8).
Precise diagnostic studies on the etiology of IP in patients with autoimmune disease, especially those with SLE, have rarely been performed. The etiology of IP in collagen disease is diverse (drugs, bronchiolites obliterans organizing pneumonia,and cytomegalovirus) (9, 10) and is usually difficult to determine. In the present patient, fine crackles in the lungs and a mild hypoxemia developed concomitantly with an elevation of serum LDH during intensive immunosuppressive therapy. At that time, we diagnosed IP based on the chest X-ray. CTfindings taken later on August 5 were also compatible with interstitial lung disease. CMV-antigenemia as demonstrated by immunocytochemical assay using HRP-C7, and the clinical improvement after the administration of gancyclovir confirmed the diagnosis. Infection by CMVis diagnosed by isolation of the virus from urine, blood, and other specimensusing virus culture. The serological method of assaying the viral titer of CMV-IgMand -IgG is convenient, but not confirmative (1 1-15) . Although the isolation of CMV from the pharynx or urine is not diagnostic of CMV-induced diseases, the isolation of CMVfrom blood has both diagnostic and prognostic value. The virus culture method has demonstrated a 60% to 70% sensitivity (16). In comparison with direct assay of CMVby PCRmethod and virus culture method, and former was demonstrated to be superior (17). The present method of detecting CMVusing HRP-C7 has been reported to be valuable for the diagnosis of CMV-induced pneumonitis in patients undergoing allogeneic BMT,and for monitoring the efficacy of gancyclovir (7 
